T. Spangenberg, A. Schoenfelder, B. Breit, A. Mann
FULL PAPER
General Procedure for the Coupling of the Directing Group with the
Unsaturated Alcohols 4 and 5 to Form the Corresponding Esters 8
and 9: Into a dry round-bottomed flask under argon was intro-
duced the unsaturated alcohol 4 or 5 (285 mg, 1.11 mmol),
oDPPBA (340 mg, 1.11 mmol), DMAP (136 mg, 1.11 mmol), DCC
(229 mg, 1.11 mmol) and dry dichloromethane (5.6 mL, 0.2 ). The
cloudy mixture was stirred at room temp. overnight. Brine was
added and the mixture was extracted three times with dichloro-
methane. The organic layer was dried with MgSO4, filtered and
removed under reduced pressure. The residue was purified by flash
chromatography (heptane/EtOAc, 9:1).
with MgSO4, filtered and the solvent removed under reduced pres-
sure. The residue was purified by flash chromatography (heptane/
EtOAc, 9:1).
tert-Butyl (4S)-2,2-Dimethyl-4-[(1R)-1-methylprop-2-enyl]-1,3-ox-
azolidine-3-carboxylate (Major Diastereomer, 20a): Light-yellow
oil. R = 0.62 (heptane/EtOAc, 7:3). IR (neat): ν = 2926, 1694,
˜
f
1384, 1364, 1254, 1175, 1085, 1056, 543 cm–1. 1H NMR (300 MHz,
50 °C, CDCl3): δ = 5.78 (m, 1 H), 5.04 (m, 2 H), 3.87 (m, 3 H),
2.75 (br. m, 1 H), 1.61 (s, 3 H), 1.55 (s, 3 H), 1.49 (s, 9 H), 1.01 (d,
J = 7.2 Hz, 3 H) ppm. 13C NMR (50 MHz, CDCl3): δ = 152.9
(CO), 140.1 (CH), 115.8 (CH2), 94.3/93.8 (rotamers, Cquat), 80.1/
79.7 (rotamers, Cquat), 64.7/64.3 (rotamers, CH2), 61.7/61.5 (CH),
40.8/39.9 (rotamers, CH), 28.7 (tBu), 27.0/26.5 (rotamers, CH3),
24.7/23.2 (rotamers, CH3), 17.2/17.0 (rotamers, CH3) ppm. HRMS
(ESI positive): calcd. for [M + H]+ 256.1907; found 256.1901.
tert-Butyl
prop-1-enyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (8): White
solid (86%). Rf = 0.78 (heptane/EtOAc, 6:4); m.p. 102 °C. [α]2D0
(4S)-4-[(1E)-3-{[2-(Diphenylphosphanyl)benzoyl]oxy}-
=
+10.7 (c = 1, CHCl ). IR (neat): ν = 2981, 1688, 1361, 1248, 1098,
˜
3
1057, 961, 943, 758, 744, 521, 501 cm–1. 1H NMR (400 MHz,
CDCl3): δ = 8.07 (m, 1 H), 7.44–7.25 (m, 12 H), 6.95 (m, 1 H),
5.71 (br. s, 2 H), 4.65 (d, J = 4.8 Hz, 2 H), 4.26–4.30 (2 br. s, 1 H),
4.03 (dd, J = 9.0, 6.3 Hz, 1 H), 3.72 (dd, J = 8.8, 2.6 Hz, 1 H), 1.6
(s, 3 H), 1.51 (s, 3 H), 1.42 (s, 9 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 166.5 (CO), 151.9 (CO), 140.7 (d, JC,P = 25.4 Hz,
tert-Butyl (4S)-2,2-Dimethyl-4-[(1S)-1-methylprop-2-enyl]-1,3-ox-
azolidine-3-carboxylate (Major Diastereomer, 21a): Light-yellow
oil. R = 0.61 (heptane/EtOAc, 7:3). IR (neat): ν = 2926, 1695,
˜
f
1374, 1364, 1254, 1175, 1084, 1054, 849 cm–1. 1H NMR (300 MHz,
50 °C, CDCl3): δ = 5.82 (m, 1 H), 5.08–5.02 (m, 2 H), 3.94–3.81
(m, 3 H), 2.75 (br. m, 1 H), 1.60 (s, 3 H), 1.49 (s, 9 H, tBu), 1.46
(s, 3 H), 1.01 (d, J = 7.18 Hz, 3 H) ppm. 13C NMR (75 MHz, 50 °C,
CDCl3): δ = 152.6 (CO), 141.1 (CH), 114.7 (CH2), 94.1 (Cquat),
79.8 (Cquat), 68.7 (CH2), 61.1 (CH), 39.9 (CH), 28.6 (tBu), 26.7 (br.
s, CH3), 24.0 (br. s, CH3), 14.2 (CH3) ppm. HRMS (ESI positive):
calcd. for [M + H]+ 256.1907; found 256.1903.
C
quat), 138.0 (d, JC,P = 12.4 Hz, Cquat), 134.4 (br. s, CH), 133.99
(d, JC,P = 20.7 Hz, CHAr), 133.97 (d, JC,P = 20.7 Hz, CHAr), 132.1
(br. s, CHAr), 130.7 (br. s, CHAr), 128.7 (CHAr), 128.5 (d, JC,P
=
7.6 Hz, CHAr), 128.2 (CHAr), 125.8 (CH), 94.1 (Cquat), 79.8 (Cquat),
68.0 (CH2), 64.9 (CH2), 58.7 (CH), 28.5 (tBu), 26.7 (CH3), 23.8
(CH3) ppm. 31P NMR (162 MHz, CDCl3):
δ = –4.53 ppm.
tert-Butyl (4S)-4-[(1R)-1-Ethylprop-2-enyl]-2,2-dimethyl-1,3-oxazol-
idine-3-carboxylate (Major Diastereomer, 20b): Light-yellow oil. Rf
C32H36NO5P (454.61): calcd. C 70.44, H 6.65, N 2.57; found C
70.6, H 6.94, N 2.38. Chiral HPLC: CHIRALCEL AD-H column
0.46 cmϫ25 cm, flow rate 0.8 mL/min (n-heptane/EtOH, 95/5),
UV 230 nm, Rt: (S)-E 10.25 min (100% E).
= 0.29 (cyclohexane/EtOAc, 8:2). IR (neat): ν = 2928, 1698, 1387,
˜
1
1365, 1259, 1176, 1091 cm–1. H NMR (300 MHz, 50 °C, CDCl3):
δ = 5.67–5.55 (m, 1 H), 5.13–5.00 (m, 2 H), 3.87–3.80 (m, 3 H),
2.46 (br. m, 1 H), 1.55 (s, 3 H), 1.48 (s, 9 H), 1.46 (s, 3 H), 1.26
(m, 2 H), 0.89 (t, J = 7.49 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 152.8/152.4 (rotamers, CO), 138.7 (CH), 117.7 (CH2),
94.2/93.2 (rotamers, Cquat), 80.0/79.7 (rotamers, Cquat), 64.7/64.3
(rotamers, CH2), 61.1/60.5 (rotamers, CH), 49.0/47.9 (rotamers,
CH), 28.6 (tBu), 26.9/26.3 (rotamers, CH3), 24.8 (CH2), 24.5/24.3
(rotamers, CH3), 12.3 (CH3) ppm. HRMS (ESI positive): calcd. for
[M + H]+ 270.2064; found 270.2052.
tert-Butyl
(4S)-4-[(1Z)-3-{[2-(Diphenylphosphanyl)benzoyl]oxy}-
prop-1-enyl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (9): White
solid (97%). Rf = 0.73 (cyclohexane/EtOAc, 1:1); m.p. 96 °C. [α]2D0
= –70.0 (c = 1, CHCl ). IR (neat): ν = 2970, 1712, 1681, 1388, 1377,
˜
3
1268, 1253, 1105, 1065, 757, 744, 696, 526, 400 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.07 (m, 1 H), 7.44–7.25 (m, 12 H), 6.95
(m, 1 H), 5.58 (m, 2 H), 4.89–5.00 (2 br. s, 1 H), 4.68 (m, 2 H),
3.98 (dd, J = 6.3, 9.0 Hz, 2 H), 3.55 (br. s, 1 H), 1.60 (s, 3 H), 1.52
(s, 3 H), 1.43 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
166.5, 151.8, 140.6 (d, JC,P = 27.0 Hz), 138.0 (d, JC,P = 10.4 Hz),
tert-Butyl (4S)-4-[(1S)-1-Ethylprop-2-enyl]-2,2-dimethyl-1,3-oxazol-
idine-3-carboxylate (Major Diastereomer, 21b): Light-yellow oil. Rf
132.1 (br. s), 134.4, 134.0 (d, JC,P = 20.8 Hz) 133.8 (d, JC,P
=
= 0.41 (cyclohexane/EtOAc, 8:2). IR (neat): ν = 2930, 1694, 1384,
˜
1363, 1255, 1174, 1089, 847, 767 cm–1 1H NMR (300 MHz,
20.6 Hz), 132.1 (br. s), 130.7 (br. s), 128.7 (d, JC,P = 4.1 Hz), 128.50
(d, JC,P = 6.5 Hz), 128.48 (d, JC,P = 7.1 Hz), 128.2, 125.2, 123.6,
94.2/93.5 (rotamers, Cquat), 80.1/79.9 (rotamers, Cquat), 68.6/68.3
(rotamers), 61.0/60.6 (rotamers), 54.5/54.3 (rotamers), 28.5 (tBu),
27.5/26.6 (rotamers), 25.0/23.9 (rotamers) ppm. 31P NMR
(162 MHz, CDCl3): δ = –4.53 ppm. C32H36NO5P (454.61): calcd.
C 70.44, H 6.65, N 2.57; found C 70.21, H 6.67, N 2.53. Chiral
HPLC: CHIRALCEL AD-H column, 0.46 cmϫ25 cm, flow rate
0.8 mL/min (n-heptane/EtOH, 95:5), UV 230 nm, Rt: (S)-E
8.18 min (100% Z).
.
CDCl3): δ = 5.65 (m, 1 H), 5.14–5.00 (m, 2 H), 3.92–3.81 (m, 3 H),
2.39 (m, 1 H), 1.59 (s, 3 H), 1.53 (s, 9 H), 1.46 (s, 3 H), 1.18 (m, 2
H), 0.88 (t, J = 7.49 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 152.9/152.4 (rotamers, CO), 139.5 (CH), 117.2/116.7 (rotamers,
CH2), 94.2/93.6 (rotamers, Cquat), 80.0/79.7 (rotamers, Cquat), 65.7
(CH2), 61.0/60.9 (rotamers, CH), 49.73/49.66 (rotamers, CH), 29.6
(tBu), 27.2/26.4 (rotamers, CH3), 24.6 (CH2), 23.1/22.7 (rotamers,
CH3), 12.2 (CH3) ppm. HRMS (ESI positive): calcd. for [M +
H]+ 270.2064; found 270.2053.
General Procedure for Allylic Substitution Reactions: Into a dry
round-bottomed flask under argon was introduced 8 or 9 (80 mg,
0.146 mmol) in anhydrous Et2O (14.6 mL, 0.01 ) followed by
CuBr·SMe2 (15 mg, 0.073 mmol). The mixture was stirred at room
temp. until the copper salt had completely dissolved (ca. 10 min)
to yield a clear light-yellow solution. Then the alkylmagnesium bro-
mide in diethyl ether at 0.1 (3 mL) was added through a syringe
pump (rate 3 mL/h) at room temp. The mixture was stirred for
an additional 1 h and saturated aqueous NH4Cl was added and
extraction with EtOAc was performed. The organic layer was dried
tert-Butyl (4S)-4-[(1R)-1-Butylprop-2-enyl]-2,2-dimethyl-1,3-oxazol-
idine-3-carboxylate (Major Diastereomer, 20c): Light-yellow oil. Rf
= 0.50 (heptane/EtOAc, 7:3). IR (neat): ν = 2929, 1694, 1384, 1363,
˜
1
1254, 1174, 1090, 913, 847, 767 cm–1. H NMR (300 MHz, 50 °C,
CDCl3): δ = 5.64 (ddd, J = 16.8, 10.3, 9.6 Hz, 1 H), 5.11 (dd, J =
10.3, 2.1 Hz, 1 H), 4.98 (dd, J = 16.8, 2.1 Hz, 1 H), 3.87 (m, 3 H),
2.55 (br. m, 1 H), 1.54 (s, 3 H), 1.48 (s, 9 H), 1.46 (s, 3 H), 1.33–
1.26 (m, 6 H), 0.90 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR (50 MHz,
CDCl3): δ = 152.8/152.3 (rotamers, CO), 139.1 (CH), 117.5 (CH2),
94.2/93.7 (rotamers, Cquat), 80.0/79.7 (rotamers, Cquat), 64.7/64.3
6012
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 6005–6018